Eventide Funds
Boston, Massachusettseventideinvestments.com
Overview
Eventide Funds is a Boston-based investment management firm founded in 2008 that offers a range of values-based investment solutions, including mutual funds, ETFs, and private investments, with a focus on sectors like healthcare, life sciences, and technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Obsidian Therapeutics | Apr 2026 | Private Placement | Co-investor |
| Avalyn Pharma | Jul 2025 | Series D | Co-investor |
| Kardium | Jul 2025 | Series D | Co-investor |
| PreciseDx | Jun 2025 | VC Round | Lead |
| Beta Bionics | Nov 2024 | Series E | Co-investor |
Key People
Robin Cheriakalath John
CEO, Co-Founder
I-hung Shih
Managing Director And Portfolio Manager
Nate Barksdale
Graphic And Web Designer (External Partner)
Dolores Bamford
Co-Chief Investment Officer, Senior Portfolio Manager
Chris Grogan
Director Of Asset Allocation Services, Portfolio Manager
Matt Galyon
Associate Director Of The Eventide Center For Faith And Investing
Darric White
Portfolio Manager
Julie Jarrett
Manager Of Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
